These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8712517

  • 1. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses.
    Soma LR, Uboh CE, Rudy JA, Smith MS.
    Am J Vet Res; 1996 Apr; 57(4):517-21. PubMed ID: 8712517
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
    Melarange R, Gentry C, O'Connell C, Blower PR, Neil C, Kelvin AS, Toseland CD.
    Agents Actions; 1992 Apr; Spec No():C82-3. PubMed ID: 1442340
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Non-steroidal anti-inflammatory drug, nabumetone, prevents indometacin-induced gastric damage via inhibition of neutrophil functions.
    Ishiwata Y, Okamoto M, Yokochi S, Hashimoto H, Nakamura T, Miyachi A, Naito Y, Yoshikawa T.
    J Pharm Pharmacol; 2003 Feb; 55(2):229-37. PubMed ID: 12635655
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites.
    Nobilis M, Mikušek J, Szotáková B, Jirásko R, Holčapek M, Chamseddin C, Jira T, Kučera R, Kuneš J, Pour M.
    J Pharm Biomed Anal; 2013 Jun; 80():164-72. PubMed ID: 23584048
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nabumetone pharmacokinetics in patients with varying degrees of renal impairment.
    Boelaert JR, Jonnaert HA, Daneels RF, Schurgers ML, Thawley AR, Undre NA, Cooper DL.
    Am J Med; 1987 Oct 30; 83(4B):107-9. PubMed ID: 3687998
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low direct cytotoxicity of nabumetone on gastric mucosal cells.
    Arai Y, Tanaka K, Ushijima H, Tomisato W, Tsutsumi S, Aburaya M, Hoshino T, Yokomizo K, Suzuki K, Katsu T, Tsuchiya T, Mizushima T.
    Dig Dis Sci; 2005 Sep 30; 50(9):1641-6. PubMed ID: 16133963
    [Abstract] [Full Text] [Related]

  • 17. Penetration of the active metabolite of nabumetone into synovial fluid and adherent tissue of patients undergoing knee joint surgery.
    Miehlke RK, Schneider S, Sörgel F, Muth P, Henschke F, Giersch KH, Münzel P.
    Drugs; 1990 Sep 30; 40 Suppl 5():57-61. PubMed ID: 2081495
    [Abstract] [Full Text] [Related]

  • 18. Population pharmacokinetics of the active metabolite of nabumetone in renal dysfunction.
    Brier ME, Sloan RS, Aronoff GR.
    Clin Pharmacol Ther; 1995 Jun 30; 57(6):622-7. PubMed ID: 7781261
    [Abstract] [Full Text] [Related]

  • 19. The unique pharmacologic profile of nabumetone.
    Blower PR.
    J Rheumatol Suppl; 1992 Nov 30; 36():13-9. PubMed ID: 1474529
    [Abstract] [Full Text] [Related]

  • 20. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
    Miehlke RK, Schneider S, Sörgel F, Muth P, Henschke F, Fedder M.
    Z Rheumatol; 1991 Nov 30; 50(2):103-8. PubMed ID: 1872041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.